Literature DB >> 21563237

Analysis of multiple sclerosis lesions using a fusion of 3.0 T FLAIR and 7.0 T SWI phase: FLAIR SWI.

Günther Grabner1, Assunta Dal-Bianco, Melanie Schernthaner, Karl Vass, Hans Lassmann, Siegfried Trattnig.   

Abstract

PURPOSE: To improve multiple sclerosis (MS) research by introducing a new type of contrast, namely, the combination of fluid-attenuated inversion recovery (FLAIR) data acquired at 3.0 T and 7.0 T susceptibility-weighted imaging (SWI) phase data. The approach of this new contrast is whole-brain coverage with 3.0 T-FLAIR data for lesion detection--currently limited at 7.0 T due to specific absorption rate (SAR) limits--overlaid with high-resolution, small vessel, and iron-related 7.0 T SWI contrast. Lesion analysis in terms of penetrating veins and local iron depositions were performed.
MATERIALS AND METHODS: Data from 10 MS patients were acquired at 3.0 T and at 7.0 T. FLAIR data, acquired at 3.0 T, were registered to 7.0 T SWI phase data and SWI image processing was performed using 3.0 T FLAIR data instead of SWI magnitude data.
RESULTS: A total of 299 MS plaques were detected in eight MS patients. Penetrating veins were found in 75 MS plaques, iron depositions in 48 MS plaques, and veins accompanied with iron depositions in 44 MS plaques.
CONCLUSION: FLAIR-SWI provides radiologically known, hyperintense definition of MS lesions overlaid with high-resolution visualization of iron deposits and venous blood vessels and offers new insights into MS lesions.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21563237     DOI: 10.1002/jmri.22452

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  27 in total

1.  Gradient echo plural contrast imaging--signal model and derived contrasts: T2*, T1, phase, SWI, T1f, FST2*and T2*-SWI.

Authors:  Jie Luo; Bharathi D Jagadeesan; Anne H Cross; Dmitriy A Yablonskiy
Journal:  Neuroimage       Date:  2012-01-28       Impact factor: 6.556

2.  FLAIR2: A Combination of FLAIR and T2 for Improved MS Lesion Detection.

Authors:  V Wiggermann; E Hernández-Torres; A Traboulsee; D K B Li; A Rauscher
Journal:  AJNR Am J Neuroradiol       Date:  2015-10-08       Impact factor: 3.825

3.  Veins in plaques of multiple sclerosis patients - a longitudinal magnetic resonance imaging study at 7 Tesla.

Authors:  Assunta Dal-Bianco; Simon Hametner; Günther Grabner; Melanie Schernthaner; Claudia Kronnerwetter; Andreas Reitner; Clemens Vass; Karl Kircher; Eduard Auff; Fritz Leutmezer; Karl Vass; Siegfried Trattnig
Journal:  Eur Radiol       Date:  2015-04-23       Impact factor: 5.315

Review 4.  Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process.

Authors:  Àlex Rovira; Mike P Wattjes; Mar Tintoré; Carmen Tur; Tarek A Yousry; Maria P Sormani; Nicola De Stefano; Massimo Filippi; Cristina Auger; Maria A Rocca; Frederik Barkhof; Franz Fazekas; Ludwig Kappos; Chris Polman; David Miller; Xavier Montalban
Journal:  Nat Rev Neurol       Date:  2015-07-07       Impact factor: 42.937

5.  The "central vein sign": is there a place for susceptibility weighted imaging in possible multiple sclerosis?

Authors:  Thomas Kau; Manuel Taschwer; Hannes Deutschmann; Martina Schönfelder; Jörg R Weber; Klaus A Hausegger
Journal:  Eur Radiol       Date:  2013-02-22       Impact factor: 5.315

6.  Gradient echo magnetic resonance imaging correlates with clinical measures and allows visualization of veins within multiple sclerosis lesions.

Authors:  Jie Luo; Dmitriy A Yablonskiy; Charles F Hildebolt; Samantha Lancia; Anne H Cross
Journal:  Mult Scler       Date:  2013-07-08       Impact factor: 6.312

7.  Improved differentiation between MS and vascular brain lesions using FLAIR* at 7 Tesla.

Authors:  Iris D Kilsdonk; Mike P Wattjes; Alexandra Lopez-Soriano; Joost P A Kuijer; Marcus C de Jong; Wolter L de Graaf; Mandy M A Conijn; Chris H Polman; Peter R Luijten; Jeroen J G Geurts; Mirjam I Geerlings; Frederik Barkhof
Journal:  Eur Radiol       Date:  2013-12-09       Impact factor: 5.315

8.  Morphological features of MS lesions on FLAIR* at 7 T and their relation to patient characteristics.

Authors:  Iris D Kilsdonk; Alexandra Lopez-Soriano; Joost P A Kuijer; Wolter L de Graaf; Jonas A Castelijns; Chris H Polman; Peter R Luijten; Jeroen J J G Geurts; Frederik Barkhof; Mike P Wattjes
Journal:  J Neurol       Date:  2014-04-29       Impact factor: 4.849

9.  FLAIR*: a combined MR contrast technique for visualizing white matter lesions and parenchymal veins.

Authors:  Pascal Sati; Ilena C George; Colin D Shea; María I Gaitán; Daniel S Reich
Journal:  Radiology       Date:  2012-10-16       Impact factor: 11.105

10.  Phase white matter signal abnormalities in patients with clinically isolated syndrome and other neurologic disorders.

Authors:  J Hagemeier; M Heininen-Brown; T Gabelic; T Guttuso; N Silvestri; D Lichter; L E Fugoso; N Bergsland; E Carl; J J G Geurts; B Weinstock-Guttman; R Zivadinov
Journal:  AJNR Am J Neuroradiol       Date:  2014-05-29       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.